Exact Mass: 340.2249622
Exact Mass Matches: 340.2249622
Found 500 metabolites which its exact mass value is equals to given mass value 340.2249622,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pentamidine
C19H24N4O2 (340.18991639999996)
Pentamidine is only found in individuals that have used or taken this drug. It is an antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [PubChem]The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Mepenzolate
C21H26NO3+ (340.1912586000001)
Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
dimethisterone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Methantheline
C21H26NO3+ (340.1912586000001)
Methantheline is a synthetic antispasmodic. Antispasmodics are used to relieve cramps or spasms of the stomach, intestines, and bladder. Methantheline is used to treat intestine or stomach ulcers (peptic ulcer disease), intestine problems (irritable bowel syndrome), pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, or urinary problems (reflex neurogenic bladder in children). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
Norethindrone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
9alpha-Fluoro-17alpha-methyl-5beta-androstane-3alpha,11beta,17-triol
17-(1H-Imidazol-4-yl)androst-5-en-3-ol
C22H32N2O (340.25145019999997)
17alpha-Ethynyl-5alpha-androst-2-en 17beta-acetate
Perindoprilat
Perindoprilat is a metabolite of perindopril. Perindopril, or perindopril arginine, (trade names include Coversyl and Aceon) is a long-acting ACE inhibitor. Perindopril is used to treat high blood pressure, heart failure or stable coronary artery disease. It is also available in a generic form, perindopril erbumine. (Wikipedia) D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-[(3-Methylphenyl)amino]pyrimidine-5-Carboxamide
C18H24N6O (340.20114939999996)
pentamidine
C19H24N4O2 (340.18991639999996)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent [Raw Data] CB201_Pentamidine_pos_50eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_40eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_30eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_20eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_10eV_isCID-10eV_rep000006.txt KEIO_ID P209; [MS2] KO009179 KEIO_ID P209; [MS3] KO009180 KEIO_ID P209
9-Fluoro-17alpha-methyl-5alpha-androstane-3beta,11beta,17-triol
Canrenone
Canrenone is the major metabolite of spironolactone. Spironolactone is a competitive aldosterone receptor antagonist (ARA), has traditionally been the treatment of first choice in idiopathic hyperaldosteronism (IHA) and for preoperative management of aldosterone producing adenoma (APA), and its therapeutic properties are attributable to active metabolite canrenone. Canrenone and the K+ salt of canrenoate are also in clinical use: they avoid the formation of intermediate products with anti-androgenic and progestational actions, resulting in a decreased incidence of side effects. (PMID: 10790593) [HMDB] Canrenone is the major metabolite of spironolactone. Spironolactone is a competitive aldosterone receptor antagonist (ARA), has traditionally been the treatment of first choice in idiopathic hyperaldosteronism (IHA) and for preoperative management of aldosterone producing adenoma (APA), and its therapeutic properties are attributable to active metabolite canrenone. Canrenone and the K+ salt of canrenoate are also in clinical use: they avoid the formation of intermediate products with anti-androgenic and progestational actions, resulting in a decreased incidence of side effects. (PMID:10790593). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.
Plastoquinone 3
Plastoquinone 3 is found in green vegetables. Plastoquinone 3 is a constituent of spinach chloroplasts (Spinacia oleracea). Constituent of spinach chloroplasts (Spinacia oleracea). Plastoquinone 3 is found in green vegetables and spinach.
14,19-Dihydroaspidospermatine
14,19-Dihydroaspidospermatine is an alkaloid from Aspidosperma quebracho-blanco (quebracho
1,1'-[1,11-Undecanediylbis(oxy)]bisbenzene
1,1-[1,11-Undecanediylbis(oxy)]bisbenzene is found in nuts. 1,1-[1,11-Undecanediylbis(oxy)]bisbenzene is isolated from the leaves of Arachis hypogaea (peanuts) infected with Puccinia arachidis. Isolated from the leaves of Arachis hypogaea (peanuts) infected with Puccinia arachidis. 1,1-[1,11-Undecanediylbis(oxy)]bisbenzene is found in nuts.
Piperochromenoic acid
Piperochromenoic acid is found in herbs and spices. Piperochromenoic acid is a constituent of the leaves of Piper auritum (Veracruz pepper). Constituent of the leaves of Piper auritum (Veracruz pepper). Piperochromenoic acid is found in herbs and spices.
2,2'-Methylenebis(6-tert-butyl-p-cresol)
2,2'-Methylenebis(4-methyl-6-tert-butylphenol) is a diarylmethane. 2,2′-Methylenebis[4-methyl-6-tert-butylphenol]. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=119-47-1 (retrieved 2024-08-26) (CAS RN: 119-47-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
3-[2-(3-Guanidino-2-methyl-3-oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide
C19H24N4O2 (340.18991639999996)
Dimethisterone
[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene
Medrogestone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives D000970 - Antineoplastic Agents
Norethindrone acetate
Pexacerfont
C18H24N6O (340.20114939999996)
Spirolactone SC 14266
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
Terguride
2-alpha-Ethoxydihydrophytuberin
2-alpha-ethoxydihydrophytuberin is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units. 2-alpha-ethoxydihydrophytuberin is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 2-alpha-ethoxydihydrophytuberin can be found in potato, which makes 2-alpha-ethoxydihydrophytuberin a potential biomarker for the consumption of this food product.
2-beta-Ethoxydihydrophytuberin
2-beta-ethoxydihydrophytuberin is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units. 2-beta-ethoxydihydrophytuberin is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 2-beta-ethoxydihydrophytuberin can be found in potato, which makes 2-beta-ethoxydihydrophytuberin a potential biomarker for the consumption of this food product.
(E,E,E)-3-(Hydroxymethyl)-7,11,15-trimethyl-2,6,10-hexadecatriene-1,14,15-triol
7alpha,8-dihydroxy-5beta,8betaH,9betaH,10alpha-Labdan-15-oic acid
Poldine
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
5-carboxy-2,3-dihydro-2-(1,5-dimethyl-1E,4-hexadienyl)-7-(3-methyl-2-butenyl)benzofuran|myrsinoic acid F
(-)-Ibogalin|(-)-ibogaline|12,13-Dimethoxy-ibogamin|12,13-dimethoxy-ibogamine
(E)-10-methoxy-8-oxo-9-octadecenoate|Me ether,Me ester-(E)-10-Hydroxy-8-oxo-9-octadecenoic acid
(ent-15?鈥?-4,15,16-Trihydroxy-4,5-seco-5-rosanone|ent-4,15xi,16-trihydroxypictan-5-one
(3E,4R*,5S*)-4,5-dihydro-3-[(11E)-13,14-dihydroxytetradec-11-en-1-ylidenel]-4-hydroxy-5-methylfuran-2(3H)-one|litseatrinolide B
3-[3(R)-ETHENYL 1-METHYL 4(R)-PIPERIDYL]-1-(6-METHOXY-4-QUINOLYL)-1(S)-PROPANOL
alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone
1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose
2-[(2E,6E)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dienyl]-5-methylbenzene-1,4-diol|Furanoquinol
11-dehydro-2,3-dinor Thromboxane B2
(3E,4R*,5S*)-4,5-dihydro-3-[(12E)-11,14-dihydroxytetradec-12-en-1-ylidenel]-4-hydroxy-5-methylfuran-2(3H)-one|litseatrinolide A
(+-)-Dihydrosecodin|15,20-Duhydro-Secodine|16,17-Dihydroseconine|2-{3-[2-(5-ethyl-3,6-dihydro-2H-pyridin-1-yl)-ethyl]-indol-2-yl}-propionic acid methyl ester|Dihydrosecodin
(ent-3beta, 8beta, 15xi)-3, 8, 15, 16-Pimaranetetrol
1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester
methyl 3alpha-hydroxy-8alpha-acetoxy-tetranor-labdan-12-oate
Cleavamine, 18.beta.-carboxy-3,4.alpha.-dihydro-, methyl ester
5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate
(-)-octalactin B|4(R),5(S),8(S)-4-hydroxy-8-[(E),1(S),6(S)-6-hydroxy-1,3,7-trimethyl-2-oxo-oct-3-enyl]-5-methyl-oxocan-2-one|Octalactin B
20-methoxy-1,4,17(20)E-pregnatriene-3,16-dione|dehydroguggulsterone M
2,7,19,20-Tetrahydro-3-hydroxy-1-methylvobasan-17-oic acid ??-alctone
Gaudichaudianic acid, (-rac)
A natural product found in Piper gaudichaudianum.
6-(2-hydroxydodecan-2-yl)-3-(hydroxymethyl)-4-methoxy-2H-pyran-2-one|monascuspyrone
8-[(2E)-3,7-dimethyl-2,6-octadienyl]-2,2-dimethyl-2H-chromene-6-carboxylic acid|cumanensic acid
4,5-cis-4.5-dihydroxy-5-(1-hydroxypentadecyl)-2-cyclopenten-1-one|hygrophoron B14|hygrophorone B14
(5S,6R,8R,9R,10S,13S)-9,13-epoxylabdane-6,15,16-triol|leoleorin D
Funtudienin-oxim, Cona-3,5-dienin-7-on-oxim
C22H32N2O (340.25145019999997)
(betaxi,1S,2R,4aR,5R,6R,8aR)-decahydro-5,6-dihydroxy-beta,1,2,4a,5-pentamethylnaphthalene-1-pentanoic acid|3alpha,4alpha-dihydroxyclerodan-15-oic acid
(2E,6E,10R)-11-butoxy-10-hydroxy-3,7,11-trimethyldodeca-2,6-dienoic acid methyl ester
(2S)-2-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]-6-methoxy-2,8-dimethyl-2H-1-benzopyran|dehydrooligandrol methyl ether
6-Methoxy-1-methyl-10,11-dihydro-1,8-seco-cinchonan-9-on|6-methoxy-1-methyl-10,11-dihydro-1,8-seco-cinchonan-9-one|N-methyl dihydroquinicine
3,11beta-Dimethoxy-19-nor-17alpha-pregna-1,3,5(10)trien-20-yn-17beta-ol
Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannundecanoic acid
16,17-Dimethoxy-aspidofractin|6,17-dimethoxy-aspidofractinine
(betaxi,1S,2R,4aR,5S,8aR)-decahydro-5-hydroxy-5-hydroxymethyl-beta,1,2,4a-tetramethylnaphthalene-1-pentanoic acid|4alpha,18-dihydroxyclerodan-15-oic acid
(6E,8S,10E,14R)-3,7,11,15-tetramethylhexadeca-1,6,10-triene-3,8,14,15-tetraol
(1R,2R,4aR,5S,6R,8aR)-5-[3-(1,2-dihydroxyethyl)but-3-enyl]decahydro-1,5,6,8a-tetramethylnaphthalene-1,2-diol|(3alpha,4beta,14R,S)-neoclerod-13(16)-ene-3,4,14,15-tetrol
ent-(13S)-3beta,8-dihydroxy-labdan-15-oic acid|ent-(13S)-3beta,8-Dihydroxy-labdan-15-saeure|Lithofellic acid|Lithofellinsaeure
dihydrobotrydial ethyl ether|O-ethyldihydrobotrydial
(-)-Nb-methylraumacline|N(b)-Methylraumacline|Nb-Methylraumacline|Nbeta-methylraumacline
(11Z,13E,15S)-15-Hydroperoxy-11,13-icosadienoic acid
Canrenone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2394 INTERNAL_ID 2394; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8731 INTERNAL_ID 8731; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 4164 Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.
Poldine
[C21H26NO3]+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate
Perindoprilat
A dipeptide obtained by formal condensation of one of the carboxy groups of N-[(1S)-1-carboxyethyl]-L-norvaline with the amino group of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid. The major active metabolite of perindopril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]
[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]
Idebenone Metabolite (1,4-Benzenediol, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-)
methantheline
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
Dihydroaspidospermatine
Plastoquinone 3
Piperochromenoic acid
5-((5Z,8Z,11Z,14Z)-heptadeca-5,8,11,14-tetraen-1-yl)resorcinol
4-Ethyl 1-(2-methyl-2-propanyl) 1,4-bipiperidine-1,4-dicarboxy late
C18H32N2O4 (340.23619520000005)
Medrogestone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D000970 - Antineoplastic Agents
1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE
Terguride
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
1-[4-(4-methylcyclohexyl)cyclohexyl]-4-(trifluoromethoxy)benzene
(3aR,4R,7aS)-tert-butyl 4-(tert-butoxycarbonylamino)hexahydro-1H-isoindole-2(3H)-carboxylate
C18H32N2O4 (340.23619520000005)
1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose
[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester
C19H24N4O2 (340.18991639999996)
(2R,5S)-rel-Tetrahydro-5-propyl-2-[trans-4-(3,4,5-trifluorophenyl)cyclohexyl]-2H-pyran
4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl
2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE
4,4-Methylenebis(1,1-dimethyl-3-phenylurea)
C19H24N4O2 (340.18991639999996)
Pexacerfont
C18H24N6O (340.20114939999996)
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Penthienate
C18H30NO3S+ (340.1946290000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds
Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-
[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene
Bohemine
C18H24N6O (340.20114939999996)
Bohemine is a purine analogue and is a synthetic and selective CDK inhibitor with IC50s of 4.6 μM, 83 μM, and 2.7 μM for Cdk2/cyclin E, Cdk2/cyclin A, and Cdk9/cyclin T1, respectively. Bohemine also inhibits ERK2 with an IC50 of 52 μM and has less inhibitory effect on CDK1, CDK4 and CDK6. Bohemine has a broad spectrum anti-cancer activities[1][2].
1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine
C21H25FN2O (340.19508119999995)
Parapenzolate
C21H26NO3+ (340.1912586000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
17beta-Pyrazol-3-yl-androst-5-en-3beta-ol
C22H32N2O (340.25145019999997)
(3beta,5alpha,11beta,17beta)-9-Fluoro-17-methylandrostane-3,11,17-triol
1-(4-Ethylphenoxy)-3-(4-phenyl-1-piperazinyl)-2-propanol
(8r,9s,10r,13s,14s,17r)-10,13-Dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3h-spiro[cyclopenta[a]phenanthrene-17,2-furan]-3,5(4h,6h)-dione
1-(Cyclohexylamino)-3-(6-Methyl-3,4-Dihydro-1h-Carbazol-9(2h)-Yl)propan-2-Ol
C22H32N2O (340.25145019999997)
(9S,14S)-10,13-Dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione
(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide
C19H24N4O2 (340.18991639999996)
[3-carboxy-2-[(7E,9E)-dodeca-7,9-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
[3-carboxy-2-[(5E,7E)-dodeca-5,7-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
[3-carboxy-2-[(2E,8E)-dodeca-2,8-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
[3-carboxy-2-[(2E,4E)-dodeca-2,4-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
[3-carboxy-2-[(2E,6E)-dodeca-2,6-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
[3-carboxy-2-[(8E,10E)-dodeca-8,10-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid
2-[(E)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-enyl]benzene-1,4-diol
1-{(E)-amino[(4,6-dimethylquinazolin-2-yl)amino]methylidene}-3-cyclohexylurea
C18H24N6O (340.20114939999996)
[(10R,13S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
plakortide F free acid
A marine-derived polyketide endoperoxide that exhibits strong inhibitory activity against the opportunistic fungal pathogens Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
Myrsinoic acid F
A member of the class of benzofurans that is 2,3-dihydro-1-benzofuran substituted by a carboxy group at position 5, a prenyl group at position 7 and a 6-methylhepta-2,5-dien-2-yl group at position 2. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.
17beta-(1H-Imidazol-4-yl)androst-5-en-3beta-ol
C22H32N2O (340.25145019999997)
1,4-Benzenediol, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-
1-[(3,4-Dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine
tert-Butyl(hexyloxy)diphenylsilane
C22H32OSi (340.22223019999996)
5-[[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]methyl]-8-quinolinol
N-[(2,3-dimethoxyphenyl)methyl]-4-(4-methyl-1-piperidinyl)aniline
6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile
C19H24N4O2 (340.18991639999996)
9-Fluoro-17-methyl-5beta-androstane-3alpha,11beta,17beta-triol
3-(4-morpholinyl)-N-[(2-prop-2-enoxy-1-naphthalenyl)methyl]-1-propanamine
[(3aR,4S,9bR)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone
N-[(2S,3R,6R)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2R,3R,6R)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2R,3R,6S)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one
C19H24N4O2 (340.18991639999996)
N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]cyclobutanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2R,3S,6R)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2S,3S,6S)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2R,3S,6S)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
N-[(2S,3S,6R)-6-[2-(cyclohexylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H32N2O4 (340.23619520000005)
(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one
C19H24N4O2 (340.18991639999996)
(2S,3R)-3-geranyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophan
(2R,3R)-2-ethyl-3-hydroxy-4-[2-[[2-[(2S,3S)-2-methoxy-3-methylpentyl]cyclopropyl]methyl]cyclopropyl]butanoic acid
9-[3-[(Z)-1-hydroxynon-3-enyl]oxiran-2-yl]nonanoic acid
(E)-12-hydroxy-13-(3-pentyloxiran-2-yl)tridec-10-enoic acid
N-[(1R,2R)-2-(4-tert-butylanilino)cyclohexyl]furan-2-carboxamide
Ethyldifluoro(2,4,6-tri-tert-butylphenyl)silane
C20H34F2Si (340.23977080000003)
2,3-dihydroxypropyl (9Z,12Z)-heptadeca-9,12-dienoate
[3-carboxy-2-[(6E,9E)-dodeca-6,9-dienoyl]oxypropyl]-trimethylazanium
C19H34NO4+ (340.24877040000007)
(2S,2S)-N,N-DI-Tert-butoxycarbonyl-2,2-bipyrrolidine
C18H32N2O4 (340.23619520000005)
(4AS,5S,8AS)-8Abeta-methoxymethoxymethyl-5beta-methyl-5alpha-(3-oxopropyl)-3,4,4A,5,6,7,8,8A-octahydronaphthalen-1(2H)-one 1-ethylene acetal
Meso-N,N-DI-tert-butoxycarbonyl-2,2-bipyrrolidine
C18H32N2O4 (340.23619520000005)
2,6,11,15-Tetramethyl-6,9,11-trihydroxy-2,14-hexadecadien-8-one
[(2S)-2,3-dihydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate
mepenzolate
C21H26NO3+ (340.1912586000001)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
3alpha-hydroxy-3,5-dihydromonacolin L acid
A polyketide obtainbed by allylic hydroxylation of dihydromonacolin L acid at the 3alpha-position.
optochin
A cinchona alkaloid consisting of 10,11-dihydrocinchonan bearing hydroxy and ethoxy substituents at positions 9 and 6 respectively.
17beta-Pyrazol-3-ylandrost-5-en-3beta-ol
C22H32N2O (340.25145019999997)
17-Hydroxy-3-oxo-17alpha-pregna-1,4-diene-21-carboxylic acid, gamma-lactone
DG(16:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one
2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-4-methylphenyl)methyl]-3-methylphenol
[(1s,12s,13r,16s,17r,18r)-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]methanol
[(1r,12r,13r,16r,17r,18r)-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]methanol
methyl 2-{4,6-diethyl-6-[2-(3-ethyloxiran-2-yl)but-1-en-1-yl]-1,2-dioxan-3-yl}acetate
(3r,4r)-12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol
1-[(1r,3s,4ar,6as,10as,10bs)-1-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]ethane-1,2-diol
(10s,14r)-14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one
(1s,2r,4r,5r,8r,9r)-4-[(3r)-3,4-dihydroxy-4-methylpentyl]-4,8-dimethyltricyclo[6.3.1.0²,⁵]dodecane-1,9-diol
(1r,2s,5e,8s,9r)-6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate
(3ar,4s,5r,8as)-5-[(2s,5r)-6-chloro-5-hydroxy-6-methylheptan-2-yl]-3-methyl-8-methylidene-3a,4,5,6,7,8a-hexahydro-1h-azulen-4-ol
C20H33ClO2 (340.21689480000003)
5-[(5z,8z,11z,14z)-heptadeca-5,8,11,14-tetraen-1-yl]benzene-1,3-diol
(1r,2r,3r,4ar,5s,6r,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1,5,6,8a-tetramethyl-hexahydro-2h-naphthalene-1,2,3-triol
(3e,4r,5r)-4-hydroxy-5-methoxy-5-methyl-3-tetradecylideneoxolan-2-one
methyl 2-[(3s,4s,6r)-4,6-diethyl-6-[(1e)-2-[(2r,3s)-3-ethyloxiran-2-yl]but-1-en-1-yl]-1,2-dioxan-3-yl]acetate
methyl 2-[(1s)-1-hydroxy-2-oxopropyl]hexadec-2-enoate
(1s)-3-[(3r,4r)-3-ethenyl-1-methylpiperidin-4-yl]-1-(6-methoxyquinolin-4-yl)propan-1-ol
8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate
(2e,6e,10e,14r)-3-(hydroxymethyl)-7,11,15-trimethylhexadeca-2,6,10-triene-1,14,15-triol
(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
1-[(1r,9r,12s,19s)-12-ethyl-6-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl]ethanone
(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(3s)-5-[(1s,2r,3r,4ar,8as)-2,3-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpentanoic acid
2-[5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol
(2z,6e,10e,14s)-3-(hydroxymethyl)-7,11,15-trimethylhexadeca-2,6,10-triene-1,14,15-triol
(2r,3s,4ar,5s,6s,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-hexahydro-2h-naphthalene-2,3,6-triol
(1e,3as,3bs,9ar,9bs,11as)-1-(1-methoxyethylidene)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione
methyl (13s,15s)-15-ethyl-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
(1r)-1-[(3r,4as,5s,10as)-5-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]ethane-1,2-diol
methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
2-[3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol
7-isopropyl-1,4-dimethyl-3,5,6,7,8,8a-hexahydroazulen-6-yl 4-hydroxybenzoate
(1r,9r,12r,19r)-12-ethyl-6-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-triene-8-carbaldehyde
[(4s)-6-(acetyloxy)-4-(2-hydroxypropan-2-yl)-7-methylidenecyclodecyl]methyl acetate
methyl 2-[(3s,4s,6r)-4,6-diethyl-6-[(1e)-2-[(2s,3r)-3-ethyloxiran-2-yl]but-1-en-1-yl]-1,2-dioxan-3-yl]acetate
(3r)-5-[(1s,2r,4ar,5s,6r,8ar)-5,6-dihydroxy-1,2,4a,5-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid
[(1s,12s,13r,16s,17s,18r)-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]methanol
(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-6-methoxy-2,8-dimethylchromene
(1r,10r,15r,17s,18s)-17-ethyl-6,7-dimethoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraene
1-[(1r,9r,12r,19r)-12-ethyl-6-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl]ethanone
methyl 2-[(1r,2r,4ar,6r,8as)-2-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]acetate
(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
[6-(2,4-dimethyloct-1-en-1-yl)-4,6-diethyl-1,2-dioxan-3-yl]acetic acid
methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate
2-(4,8-dimethylnona-3,7-dien-1-yl)-6-methoxy-2,8-dimethylchromene
(5r,6r)-6-[(1e,3e,5e,7e,9e,11e)-9,11-dimethyltetradeca-1,3,5,7,9,11-hexaen-1-yl]-5-methyloxane-2,4-dione
(2r)-3-(c-hydroxycarbonimidoyl)-2-[(1-hydroxytetradec-7-en-1-ylidene)amino]propanoic acid
C18H32N2O4 (340.23619520000005)
n-[(1r,2s,5s,6s,9r,12s,13r,16s)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-7,18-dien-16-yl]carboximidic acid
C22H32N2O (340.25145019999997)
methyl 2-[(3s,4s,6r)-4,6-diethyl-6-[(1e)-2-[(2r,3r)-3-ethyloxiran-2-yl]but-1-en-1-yl]-1,2-dioxan-3-yl]acetate
(7z,11e)-3-methoxy-7,11,15-trimethyl-5,19-dioxatricyclo[13.3.1.1⁴,¹⁸]icosa-1(18),2,4(20),7,11,16-hexaene
12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
3-(11,14-dihydroxytetradec-12-en-1-ylidene)-4-hydroxy-5-methyloxolan-2-one
(1r)-1-[(2s,3s,4ar,6as,10as,10br)-2-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]ethane-1,2-diol
[(1s,12s,13r,16s,17s,18s)-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]methanol
methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate
(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate
(4r,8s)-4-hydroxy-8-[(2s,4e,7s)-7-hydroxy-4,8-dimethyl-3-oxonon-4-en-2-yl]-5-methyloxocan-2-one
4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate
[(3r,4r,6r)-4,6-diethyl-6-[(1e)-4-ethyloct-1-en-1-yl]-1,2-dioxan-3-yl]acetic acid
methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
(3e,4r,5s)-4-hydroxy-5-methoxy-5-methyl-3-tetradecylideneoxolan-2-one
(3s,7r)-3,7-dimethyl-8-{[(2z)-3-methylnon-2-enoyl]oxy}octanoic acid
(3s,4r,5r)-3-[(7z)-hexadec-7-en-1-yl]-4,5-dihydroxyoxolan-2-one
1-(2-hydroxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one
(4s,5s)-4,5-dihydroxy-5-(1-hydroxypentadecyl)cyclopent-2-en-1-one
[(1s,12s,13r,16s,17r,18s)-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]methanol
3-(3-ethenyl-1-methylpiperidin-4-yl)-1-(6-methoxyquinolin-4-yl)propan-1-ol
3-(3-ethyl-1-methylpiperidin-4-yl)-1-(6-methoxyquinolin-4-yl)propan-1-one
(4as,5r,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate
(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one
(2s)-2-{2-[(1s,2s,8ar)-5,5-bis(hydroxymethyl)-2,8a-dimethyl-1,2,3,6,7,8-hexahydronaphthalen-1-yl]ethyl}butane-1,4-diol
1-{1-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}ethane-1,2-diol
2-[(2e)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol
1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol
(2r,3r)-5-[(1r,3r,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpentane-1,2,3-triol
(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2-methylchromene-6-carboxylic acid
3-[(3r,4r)-3-ethyl-1-methylpiperidin-4-yl]-1-(6-methoxyquinolin-4-yl)propan-1-one
(3z,4r,5r)-4-hydroxy-5-methoxy-5-methyl-3-tetradecylideneoxolan-2-one
(3r,6e,9s,10e,14s)-2,6,10,14-tetramethylhexadeca-6,10,15-triene-2,3,9,14-tetrol
(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate
(4r,5r,6r,8r)-4,6,8-trimethyl-3,7-dioxodecan-5-yl (2s)-2-methyl-3-oxopentanoate
methyl 4,10-diethyl-3-hydroxy-6-methyl-8-oxotetradec-6-enoate
(3r)-5-[(1s,2r,4as,5r,6s,8ar)-5,6-dihydroxy-1,2,4a,5-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid
methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate
(1s,4s,4as,8as)-4-[(2r,5s)-5-(1-cyano-1-methylethyl)-2-methyloxolan-2-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile
C22H32N2O (340.25145019999997)
1-{12-ethyl-6-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl}ethanone
1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate
(1r,17s,18r)-17-ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.0¹,¹⁸.0⁴,¹².0⁶,¹¹]docosa-4(12),6,8,10-tetraene
14-ethyl-10-oxa-8,18-diazahexacyclo[10.8.1.1¹,¹⁴.0²,⁷.0⁸,²¹.0¹⁸,²²]docosa-2,4,6-trien-21-ol
5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,1,4a,6-tetramethyl-hexahydro-2h-naphthalene-2,3,6-triol
14-ethyl-13-methoxy-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-ol
4,6,8-trimethyl-3,7-dioxodecan-5-yl 2-methyl-3-oxopentanoate
{3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl}methanol
3,5-dihydroxy-7-(3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl)heptanoic acid
2,7-dimethyl-8-(3-methylbut-2-en-1-yl)-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5,6-dione
(2s)-7-(3-methylbut-2-en-1-yl)-2-[(2e)-6-methylhepta-2,5-dien-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid
(1s)-3-[(3r)-3-ethenyl-1-methylpiperidin-4-yl]-1-(6-methoxyquinolin-4-yl)propan-1-ol
methyl 2-[2-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]acetate
(3e,4s,5r)-3-[(11e,13s)-13,14-dihydroxytetradec-11-en-1-ylidene]-4-hydroxy-5-methyloxolan-2-one
(2s)-2-[(2s,5e)-2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran
3-(13,14-dihydroxytetradec-11-en-1-ylidene)-4-hydroxy-5-methyloxolan-2-one
(2r)-3-(c-hydroxycarbonimidoyl)-2-{[(7z)-1-hydroxytetradec-7-en-1-ylidene]amino}propanoic acid
C18H32N2O4 (340.23619520000005)
(1r,4r,7s,8s,9r,11s,12s)-7-ethoxy-12-hydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
methyl 15-ethyl-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
(4e,8e)-1-(2-hydroxyphenyl)-5,9,13-trimethyltetradeca-4,8,12-trien-1-one
8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate
4-hydroxy-5-(hydroxymethyl)-3-tetradecanoyl-5h-furan-2-one
12-ethyl-6-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-triene-8-carbaldehyde
(4as,5s,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate
[(3as)-1-isopropyl-3a-methyl-3,4,7,8-tetrahydro-2h-azulen-6-yl]methyl 4-hydroxybenzoate
12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol
2-[2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran
3,10,10-trimethyl-7-methylidenecycloundeca-3,8-dien-1-yl 4-hydroxybenzoate
methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate
4-[5-(1-cyano-1-methylethyl)-2-methyloxolan-2-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalene-1-carbonitrile
C22H32N2O (340.25145019999997)
(2s)-2-methyl-8-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)chromene-6-carboxylic acid
5-(6-chloro-5-hydroxy-6-methylheptan-2-yl)-3-methyl-8-methylidene-3a,4,5,6,7,8a-hexahydro-1h-azulen-4-ol
C20H33ClO2 (340.21689480000003)
17-ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.0¹,¹⁸.0⁴,¹².0⁶,¹¹]docosa-4(12),6,8,10-tetraene
(4s,5r,6s,8s)-4,6,8-trimethyl-3,7-dioxodecan-5-yl (2s)-2-methyl-3-oxopentanoate
4-tert-butyl-3-[(6-tert-butyl-3-hydroxy-2-methylphenyl)methyl]-2-methylphenol
7-ethoxy-12-hydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate
(3e,4s,5r)-3-[(11r,12e)-11,14-dihydroxytetradec-12-en-1-ylidene]-4-hydroxy-5-methyloxolan-2-one
1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate
7-(3-methylbut-2-en-1-yl)-2-(6-methylhepta-2,5-dien-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid
2-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol
5-[(2r,3r)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,3-dihydro-2-benzofuran
methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
methyl (13r,15s)-15-ethyl-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
(1r,4r,4ar,8as)-1-isocyano-4-[(2s,5r)-5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalene
C22H32N2O (340.25145019999997)